Search results for:
Steriwave ICU Study Shows 39.5% Pneumonia Drop
Pioneering research from Royal Columbian Hospital Foundation shows a significant decrease in pneumonia rates and establishes a new benchmark for ICU infection prevention. Ondine Biomedical Inc. (AIM: OBI) is pleased to announce that Royal Columbian Hospital Foundation (“RCHF”)’s Advancing Innovation in Medicine (“AIM”) Research Team, at one of Canada’s leading [...]
Preparing for next phase of growth
Clinical Milestones: Completed patient enrolment in the pivotal LANTERN Phase 3 U.S. trial, with results expected in Spring 2026. Real-World Evidence Expansion: SSI reduction programmes at top hospitals and real-world evidence growing globally support broader commercial opportunities. Revenue Growth and Operational Scale-up: 29% unaudited revenue growth in 2025; in-house manufacturing and facility upgrades [...]
ICU Study Accepted for Publication
Ondine Biomedical and Royal Columbian Hospital Foundation Announce Major Research Milestone: First-of-its-Kind ICU Study Accepted by 'Journal of Critical Care' Ondine Biomedical Inc. ("Ondine") and Royal Columbian Hospital Foundation ("RCHF") are pleased to announce that the pilot study evaluating nasal photodisinfection in an intensive care unit ("ICU") setting has been [...]
Steriwave receives Innovation Product Classification by UK’s NHS for alignment with long-term NHS goals
Vancouver, British Columbia, Canada - April 8, 2026 Ondine Biomedical Inc. (AIM: OBI), a global leader in light-activated antimicrobial therapies, announces that its Steriwave® nasal photodisinfection technology has been classified as an Innovation Product by NHS Supply Chain. The Innovation Product classification is applied to technologies that [...]
Ondine and Mid Yorks Win Excellence in Healthcare Partnership Award
Excellence in Healthcare Partnership Award recognises proven collaboration delivering significant SSI reductions and supporting NHS priorities Ondine Biomedical Inc. and Mid Yorkshire Teaching NHS Trust (“Mid Yorks”) have won the Excellence in Healthcare Partnership Award in the Partnership Working to Address National Healthcare Priorities (Local Projects) category, recognising their collaboration to significantly [...]
Steriwave Up for 2025 “Product of the Year” Award
Ondine’s Steriwave Shortlisted as Finalist for Prestigious 2025 Bionow Product of the Year Award Ondine Biomedical Inc. is proud to announce that its pioneering nasal photodisinfection technology, Steriwave, has been shortlisted as a finalist for the Product of the Year Award at the 2025 Bionow Awards. The Bionow Awards are [...]
Expanding Steriwave Use Across Vancouver Island
Island Health’s New Regional Powerhouse, Cowichan District Hospital, Adopts Steriwave to Lead Vancouver Island in Surgical Innovation Ondine Biomedical Inc. today announced that Cowichan District Hospital, a facility within the Island Health Authority in British Columbia, is adopting Steriwave® nasal photodisinfection as a standard component of pre-surgical protocols for its orthopedic patients [...]
Steriwave Expands into ENT Surgery in Spain
Steriwave Expands into ENT Surgery in Spain Ondine Biomedical Inc. is pleased to announce the deployment of its Steriwave® nasal photodisinfection technology into a leading ear, nose and throat (ENT) specialist group operating surgical centres in Madrid and Málaga. Many ENT procedures involve operating in, or passing through, the nasal [...]
New Independent Study Supports Photodisinfection
New Independent Study Supports Photodisinfection Ondine Biomedical Provides Biological Context for Nasal Decolonization Strategies Following Landmark Nasal Microbiome Study Ondine Biomedical Inc. (AIM: OBI), a leader in light-activated antimicrobial therapies, highlights new biological evidence supporting its photodisinfection technology in a newly published study in Nature Communications (Aggarwal et al., 2025). [...]
Ondine and Mid Yorkshire Teaching NHS Trust shortlisted for Excellence in Healthcare Partnership Award
Ondine and Mid Yorkshire Teaching NHS Trust shortlisted for Excellence in Healthcare Partnership Award for Reducing Surgical Site Infections with Nasal Photodisinfection Second national award shortlist recognises successful partnership addressing the NHS priority of reducing surgical site infections and antimicrobial resistance. Ondine Biomedical Inc and Mid Yorkshire Teaching NHS Trust [...]
For Media Information
Simon Vane Percy
Amanda Bernard
